Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

TSX:LABS - Post Discussion

Medipharm Labs Corp > 7.74 million options @ 6.5 cents to be vested in June 2024
View:
Post by firemonkey on May 30, 2024 12:55pm

7.74 million options @ 6.5 cents to be vested in June 2024

As per the NR on Dec. 22, 2023, half of the 15.48 million options (exercisable at 6.5 cents) granted to certain directors, officers and employees will be vested six months from that date. Wonder how that may impact the share price between June 24 (Monday) and before the next quarterly report around mid-August 2024.
Comment by subaru1 on May 30, 2024 12:58pm
I don't think that it is any good for us retail shareholder
Comment by okgonow on May 30, 2024 2:36pm
well i would say that if the options are bought they wont be able to sell them ....as someone said they cant buy or sell on the open market because they have insider info on who the NDA is with?? am i right in this asumption ? so if that right i would say its a positive if they all get bought up also with the volumes we have it would take 4 ever to sell them at a profit at this point , who ...more  
Comment by mdjbrown on May 30, 2024 6:58pm
firemonkey, are these 15.48 stock options require the insiders to purchase these options at .065 cents each in order to convert them into common shares, so not sure why that would affect the share price considering they are only worth a penny more as of todays share price. The RSUs are more of an concern for shareholders as insiders are given these shares making them much less risky to sell.
Comment by firemonkey on May 30, 2024 8:54pm
mdjbrown: Yes, they have up to 5 years to exercise the stock options (paying 6.5 cents/share). Both the exercising of stock options and RSUs have dilutive effects on share value. If the officers/directors/employees are not 'greedy', they could sell at lower price levels than most of us and still make reasonable profits.It would take a lot of good news for the share price to climb then ...more  
Comment by Lvlchange on May 30, 2024 10:13pm
If you have ever had the ability to buy stock options, they can be very lucrative, but they also can be underwater.  I had to wait two years for them to vest, then has two years to exercise (Vest).  If the price isn't above the stock option price, you make no money (Under water).. so if the stock price doesn't go above the trigger they would just die.  The shares dissapear.. ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities